AMICUS THERAPEUTICS, INC. — Director's Dealing 2018

Jun 15, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2018-06-07

Reporting Person: Prout Samantha Whiteman (Principal Accounting Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	5723	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options (right to buy)	$14.88	2028-03-26	Common Stock (58277)		Direct

Footnotes

F1: These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vests on March 26, 2019. The remaining options vest and become exercisable in a series of thirty-five successive equal monthly installments, beginning on April 1, 2019, with the final installment vesting on March 1, 2022.